Emany Sravan Kumar 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Emany Sravan Kumar
SVP, Chief Financial Officer
Transactions
- Award
Class A Common Stock
2024-01-17+85,000→ 267,069 total
Footnotes (1)
- [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted December 6, 2021. The earned PSUs were certified and vested on January 17, 2024.